| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/28/2009 | US7524819 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 04/28/2009 | US7524818 Pure polypeptide of sequence Tyr-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu; controlled release and liposome formulations |
| 04/28/2009 | US7524816 Peptides and supported peptides for treating skin diseases |
| 04/28/2009 | US7524812 A Omega-conopeptide, and the anitoxidant methionine, and either clonidine or baclofen; ziconotide retains its potency and is physically and chemically compatible with the analgesic; for intrathecal administration |
| 04/28/2009 | US7524503 Antigens; vaccines; isolated peptide |
| 04/28/2009 | US7524502 Modified anti-TNF alpha antibody |
| 04/28/2009 | CA2197653C Delivery of nucleic acids |
| 04/23/2009 | WO2009052449A1 Novel peptides and uses thereof |
| 04/23/2009 | WO2009026233A3 Self assembling peptide systems and methods |
| 04/23/2009 | WO2009010765A3 Lantibiotic-based compounds having antimicrobial activity |
| 04/23/2009 | US20090106864 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin |
| 04/23/2009 | US20090105449 bioadhesives that requires no receptor or cross-links to achieve maximal adhesive strength, comprising polypeptides contain a common hydrophobic core sequence flanked by positively or negatively charged amino acids sequences, biocompatible, biodegradable and possess unique self-assembling properties |
| 04/23/2009 | US20090105448 hydrogenolytic ring opening of lysobactin with hydrogen in the presence of a hydrogenation catalyst in a solvent, to form dihydrolysobactin, octahydrolysobactin or mixtures, then enzymatically cleaving the mixtures to form fragments |
| 04/23/2009 | US20090105168 Use Of HDAC And/Or DNMT Inhibitors For Treatment Of Ischemic Injury |
| 04/23/2009 | US20090105157 Peptide substance stimulating regeneration of central nervous system neurons, pharmaceutical composition on its base, and the method of its application |
| 04/23/2009 | US20090105155 Truncated lhrh formulations |
| 04/23/2009 | US20090105152 Metastin derivatives and use thereof |
| 04/23/2009 | US20090105150 Angiotensin derivatives |
| 04/23/2009 | US20090105149 Compounds comprising lpa |
| 04/23/2009 | US20090105138 Methods for treating immune mediated neurological diseases |
| 04/23/2009 | US20090105131 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 04/23/2009 | US20090105122 Selective neuropeptide y2 receptor agonists |
| 04/23/2009 | US20090105116 Polypeptide Ligands Containing Linkers |
| 04/23/2009 | US20090105091 Modified Amino Acids |
| 04/23/2009 | US20090105084 Nucleic acid molecule encoding a novel estrogen receptor beta variant |
| 04/23/2009 | US20090104214 Synthetic peptides containing the motif "YWWLXP" as anthrax toxin antidotes |
| 04/23/2009 | US20090104151 Smac mimetic dimers and trimers useful as anti-cancer agents |
| 04/23/2009 | US20090100969 Templates for controlling synthesis of nanoparticles into discrete assemblies |
| 04/22/2009 | EP2050758A1 New polypeptides and uses thereof in cancer therapy |
| 04/22/2009 | EP2049561A1 Process for the manufacture of peptides |
| 04/22/2009 | EP2049137A2 Salicylanilides enhance oral delivery of therapeutic peptides |
| 04/22/2009 | EP1468014B1 Compositions and methods for WT1 specific immunotherapy |
| 04/22/2009 | EP1392719B1 Forms of prostate specific antigens and methods for their detection |
| 04/22/2009 | EP1089757B1 Hla binding peptides and their uses |
| 04/22/2009 | CN101415724A Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 04/22/2009 | CN101412750A Bursin specific binding peptide and screening method thereof |
| 04/22/2009 | CN101412749A MUC1 tandem repeat sequences polypeptide, preparation technique thereof and use as anti-tumor medicament |
| 04/22/2009 | CN101412748A ADRA1A polypeptide with specific C-terminal and preparation of antibody thereof |
| 04/22/2009 | CN101412747A Novel cell-penetrating peptide and uses thereof |
| 04/22/2009 | CN100480270C Fusion protein of chemoattracting small peptide and dual specific antibodies |
| 04/22/2009 | CN100480259C Telomerase inhibitory peptides and uses thereof |
| 04/22/2009 | CN100479930C Biological control of nanoparticles |
| 04/21/2009 | US7521530 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor |
| 04/21/2009 | US7521528 Point mutations; for treating conditions characterized by decreases in bone mass such as osteoporosis |
| 04/21/2009 | US7521477 Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same |
| 04/21/2009 | US7521423 Exendin pharmaceutical compositions |
| 04/21/2009 | US7521421 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521057 Lamprey GnRH-III polypeptides and methods of making thereof |
| 04/21/2009 | CA2115927C Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 04/21/2009 | CA1341594C Synthetic peptides and mixtures therof for detecting hiv antibodies |
| 04/16/2009 | WO2009049223A2 Methods and compositions for the site-selective incorporation of fluorinated amino acids into polypeptides |
| 04/16/2009 | WO2009048343A1 Functional lipid constructs |
| 04/16/2009 | WO2009047762A1 Compositions and peptides for treatment of envenomation by pla2 containing venoms like bungarus multicinct venom |
| 04/16/2009 | WO2009047523A1 Protease inhibition |
| 04/16/2009 | WO2009047513A2 Antagonists of kisspeptin and uses thereof |
| 04/16/2009 | WO2009027707A3 Methods for preparing peptides, especially radio-labelled peptides |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008035222A3 Synthesis of carbohydrate-templated amino acids and methods of using same |
| 04/16/2009 | WO2007052154A3 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| 04/16/2009 | WO2007015918A3 Novel biologically active peptides and their new uses |
| 04/16/2009 | WO2006112925A3 Cxcr3 is a gliadin receptor |
| 04/16/2009 | WO2006102542A3 Diverse chemical libraries bound to small particles with paramagnetic properties |
| 04/16/2009 | WO2005035714A3 Vaccines for cancer, autoimmune disease and infections |
| 04/16/2009 | WO2004074433A3 Rag polypeptides, nucleic acids, and their use |
| 04/16/2009 | US20090099533 Virus derived antimicrobial peptides |
| 04/16/2009 | US20090099335 viral epitope for diagnosis of viral infection |
| 04/16/2009 | US20090099334 Metastin derivatives and use thereof |
| 04/16/2009 | US20090099097 Enzyme inhibition |
| 04/16/2009 | US20090099095 Novel neuroprotective peptide |
| 04/16/2009 | US20090099093 Peptide Tyrosinase Inhibitors and Uses Thereof |
| 04/16/2009 | US20090099091 Oligopeptide Tyrosinase Inhibitors and Uses Thereof |
| 04/16/2009 | US20090099090 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use of them as cancer vaccines, and methods for treatment and prevention of cancers based on them |
| 04/16/2009 | US20090099080 Mitochondria-targeted anti-tumor agents |
| 04/16/2009 | US20090099078 Nogo Receptor Antagonists |
| 04/16/2009 | US20090099068 On-growth inhibiting compounds |
| 04/16/2009 | US20090098652 Self assembling peptide systems and methods |
| 04/16/2009 | US20090098633 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 04/16/2009 | US20090098608 Methods, systems and reagents for improved immunodetection |
| 04/16/2009 | US20090098195 Influenza virus infection suppressor |
| 04/16/2009 | US20090098175 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 04/16/2009 | US20090098150 Anti-acetylated huntingtin antibodies and uses therof |
| 04/16/2009 | US20090098111 Methods for modulating checkpoint activation through TopBP1 |
| 04/16/2009 | US20090098091 Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
| 04/16/2009 | US20090098050 Calcium binding peptides |
| 04/16/2009 | US20090098049 Targeting transducible molecules to specific cell types |
| 04/16/2009 | US20090098047 Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
| 04/16/2009 | DE102007048432A1 A transglutaminase substrate which inhibits cysteine- and serine-protease and shows antibiotic properties, used e.g. for plant protection, treatment of infections and production of antibiotic film or surgical sponge |
| 04/16/2009 | CA2702470A1 Functional lipid constructs |
| 04/15/2009 | EP2048160A1 Tumor antigen based on products of the tumor suppressor gene WT1 |
| 04/15/2009 | EP2046814A2 Minimized small peptides with high affinity for factor viii and factor viii-like proteins |
| 04/15/2009 | EP2046813A2 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 04/15/2009 | EP2046778A1 Multifunctional bioactive compounds |
| 04/15/2009 | EP2046392A2 Radiodense conjugate |
| 04/15/2009 | EP1629007B1 Novel peptides that bind to the erythropoietin receptor |
| 04/15/2009 | CN101408546A Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit |
| 04/15/2009 | CN101407811A Dairy-derived antihypertensive 7 peptide tandem gene and method for synthesizing the same |
| 04/15/2009 | CN101407543A Labelled glutamine and lysine analogues |
| 04/15/2009 | CN101407541A Modified allosteric type cyclic citrulline polypeptide, and fusion protein, antibody and reagent kit thereof |
| 04/15/2009 | CN101407540A Solid phase synthesis method of leuprorelin |